Fluphenazine
Back to searchMolecule Structure
Scientific Name
Fluphenazine
Description of the Drug
Fluphenazine is a phenothiazine used to treat patients requiring long-term neuroleptic therapy.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00623
http://www.drugbank.ca/drugs/DB00623
Brand Name(s)
Not Available
Company Owner(s)
Schering Corp Sub Schering Plough Corp, Watson Laboratories Inc, Mylan Pharmaceuticals Inc, Amneal Eu Ltd, Novitium Pharma Llc, Prasco Llc Dba Prasco Laboratories, Fresenius Kabi Usa Llc, Enaltec Labs Inc, Apothecon Inc Div Bristol Myers Squibb, Lannett Holdings Inc
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Dopamine D2 receptor | SINGLE PROTEIN | ANTAGONIST | CHEMBL217 |
Clinical Trial(s)
Unichem Links
| Atlas | fluphenazine | |
| SureChEMBL | SCHEMBL19221 | |
| PharmGKB | PA449676 | |
| Human Metabolome Database | HMDB0014761 | |
| DrugBank | DB00623 | |
| PubChem: Thomson Pharma | 14832617 | |
| PubChem | 3372 | |
| Mcule | MCULE-7579992672 | |
| LINCS | LSM-3226 | |
| Nikkaji | J4.863A | |
| BindingDB | 78433 | |
| EPA CompTox Dashboard | DTXSID2023068 | |
| DrugCentral | 1212 | |
| Brenda | 97943 | |
| ChemicalBook | CB7107784 | |
| Guide to Pharmacology | 204 | |
| rxnorm | FLUPHENAZINE HYDROCHLORIDE | FLUPHENAZINE |
| KEGG Ligand | C07010 | |
| ChEBI | 5123 | |
| ZINC | ZINC000019203912 |
